March 3, 2026Open Access

Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay

Key Points

Participants with negative alpha-synuclein assay have lower hyposmia rates, indicating potential variations in the disease presentation.
About 14% of SAA- participants experienced a change in diagnosis during the study, highlighting diagnostic uncertainty.
Participants were assessed on clinical characteristics like hyposmia and brain imaging for subcortical atrophy.
Findings suggest further investigation into the implications of subcortical brain atrophy for diagnosis and treatment.

Abstract

At baseline, SAA- sPD PPMI participants have a substantially lower rate of hyposmia, but otherwise cannot be readily distinguished from SAA+ participants based on clinical characteristics. However, SAA- participants have a greater degree of subcortical brain atrophy, and approximately one out of seven SAA- participants received a change in diagnosis. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Sarah M. Brooker

Jacopo Pasquini

Seung Ho Choi

Journals

Movement Disorders

Actions

Institutions

Stanford University

University of Pennsylvania

University of California, San Diego

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha‐Synuclein Seed Amplification Assay

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study